Cell2in is developing a cell therapy
with extraordinary cell quality management system
A Game Changer for Cell Therapy
biopharmaceutical R&D experts in Korea
Developing the therapeutic effectiveness of stem cells based on a cell quality management system
Applies to all medical disciplines
with original technology
A bio-venture company, Cell2in is established in 2016 as a spin-off from the Department of Biochemistry
and Molecular Biology in Seoul National University.
We specialize in developing cell quality management system based on superior R&D expertise and
focus on producing high quality of stem cell therapy for patients.